Study of a SARS-CoV-2 Outbreak in a Belgian Military Education and Training Center in Maradi, Niger.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
27 08 2020
Historique:
received: 14 08 2020
revised: 20 08 2020
accepted: 21 08 2020
entrez: 2 9 2020
pubmed: 2 9 2020
medline: 17 9 2020
Statut: epublish

Résumé

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) compromises the ability of military forces to fulfill missions. At the beginning of May 2020, 22 out of 70 Belgian soldiers deployed to a military education and training center in Maradi, Niger, developed mild COVID-19 compatible symptoms. Immediately upon their return to Belgium, and two weeks later, all seventy soldiers were tested for SARS-CoV-2 RNA (RT-qPCR) and antibodies (two immunoassays). Nine soldiers had at least one positive COVID-19 diagnostic test result. Five of them exhibited COVID-19 symptoms (mainly anosmia, ageusia, and fever), while four were asymptomatic. In four soldiers, SARS-CoV-2 viral load was detected and the genomes were sequenced. Conventional and genomic epidemiological data suggest that these genomes have an African most recent common ancestor and that the Belgian military service men were infected through contact with locals. The medical military command implemented testing of all Belgian soldiers for SARS-CoV-2 viral load and antibodies, two to three days before their departure on a mission abroad or on the high seas, and for specific missions immediately upon their return in Belgium. Some military operational settings (e.g., training camps in austere environments and ships) were also equipped with mobile infectious disease (COVID-19) testing capacity.

Identifiants

pubmed: 32867108
pii: v12090949
doi: 10.3390/v12090949
pmc: PMC7552053
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10915-9
pubmed: 1438297
Mil Med. 2020 Sep 18;185(9-10):e1624-e1631
pubmed: 32484225
Nat Med. 2020 Sep;26(9):1398-1404
pubmed: 32647358
Nat Med. 2020 Jun;26(6):845-848
pubmed: 32350462
Nat Protoc. 2017 Jun;12(6):1261-1276
pubmed: 28538739
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
J Am Med Inform Assoc. 2020 Aug 1;27(8):1293-1299
pubmed: 32348469
J Clin Microbiol. 2020 May 26;58(6):
pubmed: 32229605
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):714-721
pubmed: 32525850
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
Rev Med Suisse. 2020 Apr 29;16(N° 691-2):849-851
pubmed: 32348051
Front Microbiol. 2020 Jul 22;11:1800
pubmed: 32793182
Bull World Health Organ. 2020 Jul 1;98(7):495-504
pubmed: 32742035
New Microbes New Infect. 2020 Jul;36:100696
pubmed: 32509310

Auteurs

Jean-Paul Pirnay (JP)

Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, 1120 Brussels, Belgium.

Philippe Selhorst (P)

Unit of Virology, Department of Biomedical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium.

Christel Cochez (C)

Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, 1120 Brussels, Belgium.

Mauro Petrillo (M)

European Commission, Directorate-General Joint Research Centre (JRC), 1050 Brussels, Belgium.

Vincent Claes (V)

Clinical Laboratory, Queen Astrid Military Hospital, 1120 Brussels, Belgium.

Yolien Van der Beken (Y)

Clinical Laboratory, Queen Astrid Military Hospital, 1120 Brussels, Belgium.

Gilbert Verbeken (G)

Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, 1120 Brussels, Belgium.

Julie Degueldre (J)

Clinical Laboratory, Queen Astrid Military Hospital, 1120 Brussels, Belgium.

France T'Sas (F)

Clinical Laboratory, Queen Astrid Military Hospital, 1120 Brussels, Belgium.

Guy Van den Eede (G)

European Commission, Directorate-General Joint Research Centre (JRC), 1050 Brussels, Belgium.

Wouter Weuts (W)

Queen Astrid Military Hospital, 1120 Brussels, Belgium.

Cedric Smets (C)

14th Medical Battalion, 1800 Peutie, Belgium.

Jan Mertens (J)

Medical Component, Ministry of Defense, 1140 Brussels, Belgium.

Philippe Geeraerts (P)

Medical Component, Ministry of Defense, 1140 Brussels, Belgium.

Kevin K Ariën (KK)

Department of Biomedical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium.
Department of Biomedical Sciences, University of Antwerp, 2610 Antwerp, Belgium.

Pierre Neirinckx (P)

Medical Component, Ministry of Defense, 1140 Brussels, Belgium.

Patrick Soentjens (P)

Center for Infectious Diseases, Queen Astrid Military Hospital, 1120 Brussels, Belgium.
Department of Clinical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH